Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/1/2026
-
Ticker Report
3/29/2026
-
Ticker Report
3/17/2026
-
TipRanks Financial Blog
3/16/2026
-
TipRanks Financial Blog
3/14/2026
-
Ticker Report
3/12/2026
-
Globe Newswire
3/11/2026
-
TipRanks Financial Blog
3/6/2026
-
The Fly
3/6/2026
-
Globe Newswire
2/20/2026
-
Ticker Report
2/20/2026
-
TipRanks Financial Blog
2/20/2026
-
Globe Newswire
2/17/2026
-
The Fly
2/17/2026
-
Globe Newswire
2/14/2026
-
Ticker Report
1/29/2026
-
The Fly
1/27/2026
-
SeekingAlpha.com: All News
1/27/2026
-
Seeking Alpha - Healthcare
1/27/2026
-
The Fly
1/27/2026
-
GuruFocus
1/27/2026
-
Globe Newswire
12/30/2025
-
TipRanks Financial Blog
12/29/2025
-
GuruFocus
12/29/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 6, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 327 7078
Address
360 Massachusetts Avenue
Acton, MA 01720
Acton, MA 01720
Country
Year Founded
Business Description
Sector
Industry
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are...
more